LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Hepatitis C Virus

New USPSTF Hepatitis C Virus (HCV) Screening Recommendation

In 2016, there were an estimated 2.4 million people living with hepatitis C in the United States. Many people have no symptoms and don’t know they are infected, so their illness my not be diagnosed. According to the CDC, approximately 75%-80% of people who become infected with hepatitis C virus will develop a chronic infection.1

Approximately 6 in 100 infants who are born to mothers with hepatitis C become infected with the hepatitis C virus. The risk becomes greater if the mother has both HIV and hepatitis C.1

USPSTF guidelines2 recommend screening for:

  • Hepatitis C Virus Infection in Adolescents and Adults: Screening asymptomatic adults (including pregnant persons) aged 18 to 79 years without known liver disease.

LabCorp, and its specialty laboratory Monogram Biosciences, offer a comprehensive menu for screening and treating patients with Hepatitis C (HCV). LabCorp was the first to develop valuable viral resistance testing for patients undergoing HCV treatment.

Reference

  1. Centers for Disease Control and Prevention. Viral Hepatitis: Hepatitis C questions and answers for the public. https://www.cdc.gov/hepatitis/hcv/cfaq.htm
  2. US Preventive Services Task Force. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. Published online March 02, 2020. doi:10.1001/jama.2020.1123